Elevated serum CA-125 levels in hemodialysis patients with peritoneal, pleural, or pericardial fluids

Sevinc A., Buyukberber S., Sari R., Kiroglu Y., Turk H., Ates M.

GYNECOLOGIC ONCOLOGY, cilt.77, ss.254-257, 2000 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 77 Konu: 2
  • Basım Tarihi: 2000
  • Doi Numarası: 10.1006/gyno.2000.5776
  • Sayfa Sayıları: ss.254-257


Objective. Serum CA-125, an ovarian tumor marker, is used especially in the follow-up of ovarian cancer for monitoring the efficacy of therapy and for early detection of recurrence. A number of benign gynecologic as well as benign and malignant nongynecologic conditions are associated with elevated serum CA-125 levels. Malignant and nonmalignant serosal fluids were also found to be associated with high serum levels of CA-125, suggesting that the presence of fluid in the serosal cavities may stimulate its release.